Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725952 | SCV000340790 | uncertain significance | not provided | 2016-04-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000354044 | SCV000514474 | benign | not specified | 2015-08-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001089343 | SCV000636465 | likely benign | Progressive myoclonic epilepsy | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002338848 | SCV002639505 | likely benign | Inborn genetic diseases | 2017-06-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003957474 | SCV004772305 | likely benign | SCARB2-related disorder | 2019-07-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |